SMS Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	-	413.99	360.4	73.08	465.83	404.23
Short-Term Investments	-	0.91	0.77	0.7	-	-
Cash & Short-Term Investments	996.79	414.91	361.16	73.78	465.83	404.23
Cash Growth	999.48%	14.88%	389.52%	-84.16%	15.24%	323.54%
Accounts Receivable	-	2,032	2,362	1,483	485.19	1,057
Other Receivables	-	153.63	118.59	171.14	182.27	169.67
Receivables	-	2,186	2,481	1,655	667.46	1,226
Inventory	-	2,847	2,337	2,235	2,511	1,378
Prepaid Expenses	-	70.52	52.54	49.33	33.07	22.18
Other Current Assets	-	25.99	107.35	93.78	93.17	62.54
Total Current Assets	-	5,545	5,339	4,106	3,771	3,093
Property, Plant & Equipment	-	5,655	4,649	4,437	4,476	4,625
Long-Term Investments	-	116.79	109.38	105.22	215.27	273.03
Other Intangible Assets	-	21.3	26.6	14.66	13.7	16.02
Other Long-Term Assets	-	188.85	217.3	132.32	119.28	114.74
Total Assets	-	11,527	10,341	8,796	8,595	8,122
Accounts Payable	-	1,139	1,513	1,074	649.92	549.54
Accrued Expenses	-	201.46	124.22	85.06	118.26	148.43
Short-Term Debt	-	1,248	1,140	937.89	679.12	708.59
Current Portion of Long-Term Debt	-	465.92	440.96	375.91	427	322.49
Current Portion of Leases	-	-	5.92	9.4	10.4	9.09
Other Current Liabilities	-	189.15	92.89	66.58	80.09	216.16
Total Current Liabilities	-	3,244	3,317	2,549	1,965	1,954
Long-Term Debt	-	1,394	1,221	1,211	1,495	1,474
Long-Term Leases	-	-	-	6.14	21.14	31.55
Pension & Post-Retirement Benefits	-	2.57	3.78	8.04	9.94	12.58
Long-Term Deferred Tax Liabilities	-	480.98	427.99	410.2	395.51	538.53
Other Long-Term Liabilities	-	9.49	7.82	6.01	5.73	5.82
Total Liabilities	-	5,130	4,978	4,191	3,892	4,017
Common Stock	-	88.65	84.65	84.65	84.65	84.65
Additional Paid-In Capital	-	1,202	698.18	698.18	698.18	698.18
Retained Earnings	-	4,931	4,279	3,807	3,905	3,307
Comprehensive Income & Other	-	174.25	301.25	15.5	15.5	15.5
Total Common Equity	7,293	6,396	5,363	4,605	4,703	4,105
Minority Interest	-	0	-	-	-	-
Shareholders' Equity	7,293	6,396	5,363	4,605	4,703	4,105
Total Liabilities & Equity	-	11,527	10,341	8,796	8,595	8,122
Total Debt	3,243	3,108	2,808	2,541	2,633	2,546
Net Cash (Debt)	-2,246	-2,693	-2,447	-2,467	-2,167	-2,142
Net Cash Per Share	-24.10	-30.37	-28.90	-29.14	-25.60	-25.30
Filing Date Shares Outstanding	90.63	88.65	84.65	84.65	84.65	84.65
Total Common Shares Outstanding	90.63	88.65	84.65	84.65	84.65	84.65
Working Capital	-	2,301	2,022	1,557	1,806	1,139
Book Value Per Share	81.83	72.15	63.36	54.40	55.56	48.50
Tangible Book Value	7,267	6,375	5,337	4,591	4,689	4,089
Tangible Book Value Per Share	81.54	71.91	63.04	54.23	55.39	48.31
Land	-	42.13	42.13	42.13	42.13	42.13
Buildings	-	1,566	1,341	1,308	1,300	1,233
Machinery	-	5,905	4,841	4,331	4,279	4,224
Construction In Progress	-	346.71	302.72	331.91	110.04	67.44

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.